Abstract

Most ovarian high-grade serous carcinomas (HGSC) arise from Serous Tubal Intraepithelial Carcinoma (STIC) lesions in the distal end of the fallopian tube (FT). Formation of STIC lesions from FT secretory cells leads to seeding of the ovarian surface, with rapid tumor dissemination to other abdominal structures thereafter. It remains unclear how nascent malignant cells leave the FT to colonize the ovary. This report provides evidence that the L1 cell adhesion molecule (L1CAM) contributes to the ability of transformed FT secretory cells (FTSEC) to detach from the tube, survive under anchorage-independent conditions, and seed the ovarian surface. L1CAM was highly expressed on the apical cells of STIC lesions and contributed to ovarian colonization by upregulating integrins and fibronectin in malignant cells and activating the AKT and ERK pathways. These changes increased cell survival under ultra-low attachment conditions that mimic transit from the FT to the ovary. To study dissemination to the ovary, we developed a tumor-ovary co-culture model. We showed that L1CAM expression was important for FT cells to invade the ovary as a cohesive group. Our results indicate that in the early stages of HGSC development, transformed FTSECs disseminate from the FT to the ovary in a L1CAM-dependent manner.

L1CAM is implicated as an important factor that enables early fallopian tube cancer precursors to seed the ovary by promoting cell survival through extracellular matrix signaling, thereby facilitating ovarian cancer growth.

Details

Title
L1CAM is required for early dissemination of fallopian tube carcinoma precursors to the ovary
Author
Doberstein, Kai 1 ; Spivak, Rebecca 2 ; Reavis, Hunter D. 2 ; Hooda, Jagmohan 3   VIAFID ORCID Logo  ; Feng, Yi 2 ; Kroeger, Paul T. 2 ; Stuckelberger, Sarah 2 ; Mills, Gordon B. 4   VIAFID ORCID Logo  ; Devins, Kyle M. 5 ; Schwartz, Lauren E. 5 ; Iwanicki, Marcin P. 6   VIAFID ORCID Logo  ; Fogel, Mina 7 ; Altevogt, Peter 8 ; Drapkin, Ronny 9   VIAFID ORCID Logo 

 University of Pennsylvania, Perelman School of Medicine, Ovarian Cancer Research Center, Philadelphia, USA (GRID:grid.25879.31) (ISNI:0000 0004 1936 8972); Medical Faculty Mannheim of the Heidelberg University, Department of Gynecology, Mannheim, Germany (GRID:grid.7700.0) (ISNI:0000 0001 2190 4373) 
 University of Pennsylvania, Perelman School of Medicine, Ovarian Cancer Research Center, Philadelphia, USA (GRID:grid.25879.31) (ISNI:0000 0004 1936 8972) 
 University of Pennsylvania, Perelman School of Medicine, Ovarian Cancer Research Center, Philadelphia, USA (GRID:grid.25879.31) (ISNI:0000 0004 1936 8972); University of Pittsburgh, Hillman Cancer Center, Pittsburgh, USA (GRID:grid.478063.e) (ISNI:0000 0004 0456 9819) 
 Oregon Health and Science University, Knight Cancer Institute, Portland, USA (GRID:grid.5288.7) (ISNI:0000 0000 9758 5690) 
 University of Pennsylvania, Perelman School of Medicine, Department of Pathology and Laboratory Medicine, Philadelphia, USA (GRID:grid.25879.31) (ISNI:0000 0004 1936 8972) 
 Chemical Biology and Biological Sciences, Stevens Institute of Technology, Department of Bioengineering, Chemistry, Hoboken, USA (GRID:grid.217309.e) (ISNI:0000 0001 2180 0654) 
 Kaplan Medical Center, Central Laboratories, Rehovot, Israel (GRID:grid.415014.5) (ISNI:0000 0004 0575 3669) 
 German Cancer Research Center (DKFZ), Skin Cancer Unit, Heidelberg, Germany (GRID:grid.7497.d) (ISNI:0000 0004 0492 0584) 
 University of Pennsylvania, Perelman School of Medicine, Ovarian Cancer Research Center, Philadelphia, USA (GRID:grid.25879.31) (ISNI:0000 0004 1936 8972); University of Pennsylvania, Perelman School of Medicine, Basser Center for BRCA, Abramson Cancer Center, Philadelphia, USA (GRID:grid.25879.31) (ISNI:0000 0004 1936 8972) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
23993642
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2753454517
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.